Literature DB >> 29102606

Incidence and Etiology of Presumed Fourth Cranial Nerve Palsy: A Population-based Study.

Eniolami O Dosunmu1, Sarah R Hatt2, David A Leske2, David O Hodge3, Jonathan M Holmes4.   

Abstract

PURPOSE: To determine the incidence of isolated, presumed fourth nerve palsy in a defined population, and to report the frequency of each cause.
DESIGN: Retrospective, population-based case series.
METHODS: A population-based database was used to identify all cases of isolated fourth nerve palsy in Olmsted County, Minnesota, USA diagnosed over a 15-year period (January 1, 1978 to December 31, 1992). The most likely etiology was determined by review of the entire medical record by 2 ophthalmologists. A priori definitions were applied for assigning cause. The incidence of fourth nerve palsy and the frequency of each etiology were calculated. Decade of life at presentation was recorded.
RESULTS: Seventy-three patients (74 episodes, 70 [95%] unilateral) were identified. Mean age at presentation was 41.8 (range 3.3-81.6) years. The age- and sex-adjusted annual incidence rate was 5.73 per 100 000 per year (95% confidence interval [CI] 4.31-7.14). The most common etiology was presumed congenital (49%), followed by hypertension (18%) and trauma (18%). One patient (1%) had fourth nerve palsy owing to a known intracranial neoplasm. For 3 patients (4%) the cause of fourth nerve palsy was undetermined. The most common decade of presentation overall was the fourth decade, including for presumed congenital cases.
CONCLUSIONS: In this population-based study, the majority of isolated fourth nerve palsies were presumed congenital, even though they presented throughout adulthood. Other etiologies such as hypertension and trauma were less frequent, and in no case was an isolated fourth nerve palsy the presenting sign of an intracranial tumor.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29102606      PMCID: PMC5784757          DOI: 10.1016/j.ajo.2017.10.019

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  29 in total

1.  Incidence, types, and lifetime risk of adult-onset strabismus.

Authors:  Jennifer M Martinez-Thompson; Nancy N Diehl; Jonathan M Holmes; Brian G Mohney
Journal:  Ophthalmology       Date:  2013-12-08       Impact factor: 12.079

2.  Incidence and types of childhood hypertropia: a population-based study.

Authors:  Megha M Tollefson; Brian G Mohney; Nancy N Diehl; James P Burke
Journal:  Ophthalmology       Date:  2006-04-27       Impact factor: 12.079

3.  The patient record in epidemiology.

Authors:  L T Kurland; C A Molgaard
Journal:  Sci Am       Date:  1981-10       Impact factor: 2.142

4.  Acquired superior oblique palsy. Diagnosis and management.

Authors:  E Khawam; A B Scott; A Jampolsky
Journal:  Arch Ophthalmol       Date:  1967-06

5.  The causes of paralysis of the third, fourth and sixth cranial nerves.

Authors:  C W Rucker
Journal:  Am J Ophthalmol       Date:  1966-05       Impact factor: 5.258

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Superior oblique palsy: diagnosis and classification.

Authors:  F D Ellis; E M Helveston
Journal:  Int Ophthalmol Clin       Date:  1976

8.  Fourth nerve palsy: historical review and study of 215 inpatients.

Authors:  J R Keane
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

9.  Acquired palsy of the oculomotor, trochlear and abducens nerves.

Authors:  P A Tiffin; C J MacEwen; E A Craig; G Clayton
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

10.  Executive summary: Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more
  9 in total

1.  Development of acquired non-accommodative esotropia in a patient without a trochlear nerve.

Authors:  Hee Kyung Yang; Jae Hyoung Kim; Jeong-Min Hwang
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

2.  Association between migraine and risk of ocular motor cranial nerve palsy.

Authors:  Soolienah Rhiu; Kyungdo Han; Juhwan Yoo; Kyung-Ah Park; Sei Yeul Oh
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

3.  Types of Surgery Performed and Reoperation Rate for Congenital Superior Oblique Palsy: a Claims Database Study.

Authors:  Hwan Heo; Scott R Lambert
Journal:  Acta Ophthalmol       Date:  2021-10-24       Impact factor: 3.988

4.  Vertical Comitance of Hypertropia in Congenital and Acquired Superior Oblique Palsy.

Authors:  Joseph L Demer
Journal:  J Neuroophthalmol       Date:  2021-10-08       Impact factor: 4.415

5.  Liver enzymes and risk of ocular motor cranial nerve palsy: a nationwide population-based study.

Authors:  Joonhyoung Kim; Kyungdo Han; Juhwan Yoo; Kyung-Ah Park; Sei Yeul Oh
Journal:  Neurol Sci       Date:  2021-11-23       Impact factor: 3.830

6.  Isolated trochlear palsy as the only presentation of midbrain infarction: a case report.

Authors:  Wen-Ching Chen; Ying-Sheng Li; Poyin Huang
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

7.  Ocular motor cranial nerve palsy and increased risk of stroke in the general population.

Authors:  Sang Jun Park; Hee Kyung Yang; Seong Jun Byun; Kyu Hyung Park; Jeong-Min Hwang
Journal:  PLoS One       Date:  2018-10-15       Impact factor: 3.240

8.  Onodi cell mucocele causing isolated trochlear nerve palsy: A case report.

Authors:  Kyung Won Kwon; Jin Seok Oh; Ji Won Kim; Roh-Eul Yoo; Jae-Goo Kang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

9.  Can Binocular Alignment Distinguish Hypertropia in Sagging Eye Syndrome From Superior Oblique Palsy?

Authors:  Qi Wei; Robert A Clark; Joseph L Demer
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-09-01       Impact factor: 4.925

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.